Meyka Pro banner
Cosmos Health Inc.

Cosmos Health Inc. Fundamental Analysis (NASDAQ: COSM)

COSMNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.21
$0.02(6.89%)
U.S. Market is Open · 13:58

Cosmos Health Inc. Fundamental Analysis (NASDAQ: COSM)

Cosmos Health Inc. (NASDAQ: COSM) shows weak financial fundamentals with a PE ratio of -0.32, profit margin of -30.41%, and ROE of -96.48%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.01

Areas of Concern

ROE-96.48%
Operating Margin-25.75%
We analyze COSM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -128.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-128.8/100

We analyze COSM's fundamental strength across five key dimensions:

Efficiency Score

Weak

COSM struggles to generate sufficient returns from assets.

ROA > 10%
-33.88%

Valuation Score

Excellent

COSM trades at attractive valuation levels.

PE < 25
-0.32
PEG Ratio < 2
-0.01

Growth Score

Weak

COSM faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

COSM maintains a strong and stable balance sheet.

Debt/Equity < 1
0.88
Current Ratio > 1
1.08

Profitability Score

Weak

COSM struggles to sustain strong margins.

ROE > 15%
-9647.54%
Net Margin ≥ 15%
-30.41%
Positive Free Cash Flow
No

Key Financial Metrics

Is COSM Expensive or Cheap?

P/E Ratio

COSM trades at -0.32 times earnings. This suggests potential undervaluation.

-0.32

PEG Ratio

When adjusting for growth, COSM's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Cosmos Health Inc. at 0.49 times its book value. This may indicate undervaluation.

0.49

EV/EBITDA

Enterprise value stands at 0.33 times EBITDA. This is generally considered low.

0.33

How Well Does COSM Make Money?

Net Profit Margin

For every $100 in sales, Cosmos Health Inc. keeps $-30.41 as profit after all expenses.

-30.41%

Operating Margin

Core operations generate -25.75 in profit for every $100 in revenue, before interest and taxes.

-25.75%

ROE

Management delivers $-96.48 in profit for every $100 of shareholder equity.

-96.48%

ROA

Cosmos Health Inc. generates $-33.88 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.88%

Following the Money - Real Cash Generation

Operating Cash Flow

Cosmos Health Inc. generates limited operating cash flow of $-12.54M, signaling weaker underlying cash strength.

$-12.54M

Free Cash Flow

Cosmos Health Inc. generates weak or negative free cash flow of $-12.82M, restricting financial flexibility.

$-12.82M

FCF Per Share

Each share generates $-0.24 in free cash annually.

$-0.24

FCF Yield

COSM converts -98.25% of its market value into free cash.

-98.25%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.32

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.88

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.96

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

-0.63

vs 25 benchmark

How COSM Stacks Against Its Sector Peers

MetricCOSM ValueSector AveragePerformance
P/E Ratio-0.3231.56 Better (Cheaper)
ROE-96.48%441.00% Weak
Net Margin-30.41%18300.00% Weak
Debt/Equity0.880.73 Weak (High Leverage)
Current Ratio1.085.63 Neutral
ROA-33.88%1512.00% Weak

COSM outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cosmos Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ